根治性前列腺切除术在转移性前列腺癌患者中的研究进展(4)
[19] Natarajan S，Raman S，Priester AM，et al. Focal Laser Ablation of Prostate Cancer：Phase I Clinical Trial [J]. J Urol，2016，196(1)：68-75.
[20] Hamdy FC，Elliott D，le Conte S，et al. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer：the PART feasibility RCT [J]. Health Technol Assess，2018，22(52)：1-96.
[21] Kim EH，Bullock AD. Surgical Management for Prostate Cancer [J]. Mo Med，2018，115(2)：142-145.
[22] Peacock M，Quirt J，James Morris W，et al. Population-based 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia [J]. Can Urol Assoc J，2015，9(11-12)：409-413.
[23] Abdollah F，Briganti A，Montorsi F，et al. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer：a population-based analysis [J]. Int J Urol，2013，20(5)：548-549.
[24] Psaila B，Lyden D. The metastatic niche：adapting the foreign soil [J]. Nat Rev Cancer，2009，9(4)：285-293.
[25] Bayne CE，Williams SB，Chapin BF，et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer：Current Concepts and Future Perspectives [J]. Eur Urol，2017，71(2)：e51.
[26] Kim MY，Oskarsson T，Acharyya S，et al. Tumor self-seeding by circulating cancer cells [J]. Cell，2009，139(7)：1315-1326.
(收稿日期：2019-03-22 本文編辑：任 念), 百拇医药(张崇剑 白宇)
[20] Hamdy FC，Elliott D，le Conte S，et al. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer：the PART feasibility RCT [J]. Health Technol Assess，2018，22(52)：1-96.
[21] Kim EH，Bullock AD. Surgical Management for Prostate Cancer [J]. Mo Med，2018，115(2)：142-145.
[22] Peacock M，Quirt J，James Morris W，et al. Population-based 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia [J]. Can Urol Assoc J，2015，9(11-12)：409-413.
[23] Abdollah F，Briganti A，Montorsi F，et al. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer：a population-based analysis [J]. Int J Urol，2013，20(5)：548-549.
[24] Psaila B，Lyden D. The metastatic niche：adapting the foreign soil [J]. Nat Rev Cancer，2009，9(4)：285-293.
[25] Bayne CE，Williams SB，Chapin BF，et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer：Current Concepts and Future Perspectives [J]. Eur Urol，2017，71(2)：e51.
[26] Kim MY，Oskarsson T，Acharyya S，et al. Tumor self-seeding by circulating cancer cells [J]. Cell，2009，139(7)：1315-1326.
(收稿日期：2019-03-22 本文編辑：任 念), 百拇医药(张崇剑 白宇)